Skip directly to content

Atrial Fibrillation Updates

Lunes, Febrero 8, 2021

Understanding and knowledge of atrial fibrillation (AF) treatment continues to expand in 2020. 
The EAST-AFNET 4 trial, recently published in the New England Journal of Medicine, showed that an aggressive early approach to maintaining normal sinus rhythm in patients with new onset AF led to a reduction in the composite endpoint of cardiovascular death, stroke, and hospitalization with heart failure or acute coronary syndrome. 

 

 


NEJM Journal Watch summary, reutilizado con permiso del Grupo NEJM

 

Código de aprobación: PP-CVP-GLB-0377